HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuquan Wei Selected Research

N(1)-methyl-2-lysergic acid diethylamide (MIL)

1/2020Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nanoformulation.
8/2016Millepachine, a potential topoisomerase II inhibitor induces apoptosis via activation of NF-κB pathway in ovarian cancer.
10/2013Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse interleukin 27 by means of cationic liposome.
7/2013Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuquan Wei Research Topics

Disease

241Neoplasms (Cancer)
09/2022 - 06/2004
42Neoplasm Metastasis (Metastasis)
06/2022 - 04/2008
37Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 12/2005
27Carcinoma (Carcinomatosis)
01/2018 - 09/2005
23Inflammation (Inflammations)
01/2021 - 06/2005
21Breast Neoplasms (Breast Cancer)
03/2020 - 09/2005
20Hepatocellular Carcinoma (Hepatoma)
01/2020 - 07/2006
19Lung Neoplasms (Lung Cancer)
01/2022 - 12/2005
16Colonic Neoplasms (Colon Cancer)
01/2020 - 12/2004
13Carcinogenesis
01/2022 - 06/2009
13Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 12/2004
9Infections
09/2022 - 01/2013
9Melanoma (Melanoma, Malignant)
06/2022 - 01/2011
9Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 01/2009
7Necrosis
10/2021 - 01/2013
7Glioma (Gliomas)
01/2018 - 06/2009
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 11/2010
5Fibrosis (Cirrhosis)
01/2022 - 12/2014
5Bites and Stings (Sting)
10/2020 - 01/2016
5Hypoxia (Hypoxemia)
01/2019 - 01/2009
5Arthritis (Polyarthritis)
01/2018 - 11/2010
5Body Weight (Weight, Body)
09/2016 - 11/2010
5Lymphatic Metastasis
07/2016 - 06/2007
5Lewis Lung Carcinoma
01/2016 - 09/2009
5Stomach Neoplasms (Stomach Cancer)
10/2014 - 01/2009
4Hypertension (High Blood Pressure)
09/2022 - 06/2009
4Leukemia
11/2021 - 01/2008
4Wounds and Injuries (Trauma)
07/2021 - 12/2011
4Pneumonia (Pneumonitis)
01/2021 - 12/2014
4Atherosclerosis
01/2021 - 06/2012
4Mitochondrial Diseases (Mitochondrial Disease)
11/2019 - 04/2017

Drug/Important Bio-Agent (IBA)

64Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2004
27VaccinesIBA
01/2022 - 12/2004
27Pharmaceutical PreparationsIBA
01/2019 - 02/2010
23Liposomes (Liposome)IBA
01/2022 - 01/2008
22CytokinesIBA
07/2021 - 04/2008
19Cisplatin (Platino)FDA LinkGeneric
01/2021 - 12/2005
17MicellesIBA
10/2018 - 04/2011
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 12/2004
16Small Interfering RNA (siRNA)IBA
01/2021 - 01/2009
12Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2006
12Biological ProductsIBA
12/2019 - 09/2006
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2008
11Cancer VaccinesIBA
01/2022 - 12/2004
11Therapeutic UsesIBA
01/2021 - 01/2014
10Peptides (Polypeptides)IBA
01/2022 - 12/2004
10Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 07/2009
10EnzymesIBA
01/2021 - 08/2010
10AntigensIBA
01/2021 - 11/2008
10Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 08/2008
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 08/2010
10PolyethyleneimineIBA
09/2017 - 01/2011
9Heparin (Liquaemin)FDA LinkGeneric
09/2017 - 01/2011
8NanogelsIBA
09/2017 - 07/2011
8honokiolIBA
08/2011 - 01/2008
7AntibodiesIBA
10/2020 - 10/2013
7Glucose (Dextrose)FDA LinkGeneric
01/2020 - 06/2012
7Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 05/2013
7AlginatesIBA
09/2017 - 07/2011
7methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA
09/2017 - 06/2011
7CateninsIBA
02/2017 - 12/2013
7CholesterolIBA
01/2017 - 04/2011
7Ethylene Glycol (Monoethylene Glycol)IBA
01/2014 - 04/2011
6CollagenIBA
01/2022 - 01/2011
6LigandsIBA
10/2021 - 01/2012
6Messenger RNA (mRNA)IBA
01/2020 - 04/2009
6SurvivinIBA
01/2019 - 06/2010
61,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
01/2018 - 05/2009
5Histones (Histone)IBA
01/2022 - 08/2017
5AntioxidantsIBA
11/2021 - 09/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 07/2011
5Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
5Monoclonal AntibodiesIBA
11/2020 - 11/2014
5Phosphotransferases (Kinase)IBA
01/2019 - 01/2009
5LipidsIBA
09/2016 - 08/2011
5Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2015 - 07/2010
5Caspase 3 (Caspase-3)IBA
05/2014 - 09/2005
5caprolactoneIBA
01/2014 - 06/2011
5QuercetinIBA
12/2013 - 04/2009
52- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2013 - 10/2010
4Interleukin-27 (Interleukin 27)IBA
01/2022 - 05/2013
4MethyltransferasesIBA
01/2022 - 02/2016
4CaspasesIBA
10/2021 - 05/2014
4Tyrosine Kinase InhibitorsIBA
07/2021 - 12/2011
4Dinoprostone (PGE2)FDA Link
04/2020 - 05/2013
4Interleukin-15 (Interleukin 15)IBA
01/2020 - 07/2011
4Mitochondrial DNA (mtDNA)IBA
01/2020 - 01/2016
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2020 - 01/2014
4N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
01/2020 - 07/2013
4MicroRNAs (MicroRNA)IBA
01/2019 - 01/2014
4Long Noncoding RNAIBA
01/2019 - 01/2017
4Indicators and Reagents (Reagents)IBA
01/2019 - 05/2015
4ErbB Receptors (EGF Receptor)IBA
12/2018 - 05/2005
4Interleukin-12 (IL 12)IBA
10/2018 - 04/2008

Therapy/Procedure

107Therapeutics
03/2022 - 06/2004
26Immunotherapy
01/2022 - 06/2004
22Drug Therapy (Chemotherapy)
12/2021 - 11/2008
11Oral Administration
01/2019 - 09/2006
9Radiotherapy
01/2021 - 04/2010
5Aftercare (After-Treatment)
01/2018 - 09/2005